Effect Aerobic Training on Women With Breast Cancer After Chemotherapy
Study Details
Study Description
Brief Summary
Introduction: The purpose of this study was to determine the effect of twelve weeks of aerobic exercise program on erythrocyte levels in women with breast cancer after chemotherapy.
Methods: Thirty women with breast cancer after chemotherapy of Sydalshhda hospital (aged between 47-65 years) volunteered for this study, and then randomly selected an exercise (n = 15) and control (n = 15) groups. Exercise group completed a twelve-week aerobic exercise training program consisted of three sessions per week, each session lasting 30 to 60 minutes 50 to 75 percent of their maximum heart rate reserve, while the control group were followed. Blood samples including red blood cell counts (RBC), hematocrit (HCT), hemoglobin (HB), peak oxygen consumption before and after 12 weeks of aerobic exercise were measured. For analysis of data, repeated-measures analysis of variance (ANOVA) was used.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 1 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: breast cancer Effect of exercise training on breast cancer patient |
Behavioral: Exercise training
twelve-week aerobic exercise training program consisted of three sessions per week, each session lasting 30 to 60 minutes 50 to 75 percent of their maximum heart rate reserve
|
Outcome Measures
Primary Outcome Measures
- effect of exercise on CBC parameters (measured by ELISA methods) [up to 12 weeks]
Secondary Outcome Measures
- effect of exercise on peak oxygen consumption, measured by vo2 max test [up to 12 weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
women with breast cancer , who can do a physical, physiological and psychological test; and did not have exercise limitations due to neuromuscular and/or musculoskeletal disease; did not have any health problems that prevented maximum effort on the treadmill test.
Exclusion Criteria:
women under erythropoietin treatments, uncontrolled cardiovascular or pulmonary diseases, uncontrolled arrhythmias, orthopedic conditions that would limit exercise participation, refusal for randomization, or participation in aerobic exercise training within 3 months before beginning the study.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University of Isfahan
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 201527904IR